[1] 丁晓东. 美国肝病学会成人肝硬化腹水诊疗指南(2009年版).肝脏,2009,14(3):245-246. [2] 张彤. 肝硬化患者的急性肾损伤.肝脏,2009,14(3):234-237. [3] Krag A,Bensen F,Henriksen JH,et a1.Low cardiac output predicts development of hepatorenal syndrome and survival in patients with cirrhosis and ascites.Gut,2010,59(1):105-110. [4] EASL. Clinical practice guidelines on the management of ascites,spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. Hepatology,2012,33:55-69. [5] 张启迪. 肝肾综合征诊治研究进展. 胃肠病学,2013,18(12):756-759. [6] 闫涛,李克,王慧芬. 肝肾综合征发生机制. 实用肝脏病杂志,2009,12(3):237-240. [7] 聂鑫,贺勇,李贵星,等.肝肾综合征与肝性脑病的关系研究.中国实验诊断学,2012,16(3):475-478. [8] Janicko M,Veselíny E,Abraldes JG,et al.Serum sodium identifies patients with cirrhosis at high risk of hepatorenal syndrome. Gastroenterology,2013,51(7):628-634. [9] Rafat C,Burbach M,Brochériou I,et al. Bilirubin-associated acute tubular necrosis in a kidney transplant recipient. Am J Kidney Dis,2013,61(5):782-785. [10] 吴晓庆.肝衰竭预后的危险因素分析.临床肝胆病杂志,2013,18(4):294-296. [11] 汤伟亮,赵钢德,董志霞,等. 乙型肝炎相关肝功能衰竭患者预测危险因素及预后模型建立. 肝脏,2011,16(5):367-369. [12] Park JM. Cystatin C is a good predictor of hepatorenal syndrome and survival in patients with cirrhosis who have normal serum creatinine levels. Hepatogastroenterology,2012,59(116):1168-1173. [13] 杨进孙,汪长生. 乙型肝炎肝硬化并发肝肾综合征危险因素Logistic回归分析. 中国病原生物学杂志,2012,7(2):115-117. [14] 刘正刚. 肝硬化患者发生肝肾综合征的危险因素分析.中国当代医药,2011,18(10):37-39. [15] Kakazu E,Kondo Y,Shimosegawa T.The relationship between renal dysfunction and abnormalities of the immune system in patients with decompensated cirrhosis. Gastroenterology,2012,50(12):123-126. [16] 苗强,聂鑫,高宝秀,等. 全身炎症反应与肝肾综合征关系的研究. 实用肝脏病杂志,2013,16(1):38-40. [17] 王义国,闫明先. 肝硬化患者自发性腹膜炎后肾功能的变化与预后的关系. 中华医院感染学杂志,2002,12(9):658-659. [18] 吕日英.重型肝炎患者并发肝肾综合征的危险因素.临床肝胆病杂志,2012,28(7):542-544. |